Global Tumor Ablation Market Size, Share, Trends, Analysis and Forecasts by 2027

Tumor ablation is a minimally invasive procedure that is used to treat lung, liver, kidney, bone, prostate, spine and other tumors. There are several types of tumor ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Percutaneous Ethanol Ablation (PEI), among others. These procedures are performed percutaneously through a small hole the size of a pen tip often with sedation and local anesthesia. During the procedure, an imaging professional uses a CT scanner to exactly locate the tumor and then guides a specialized needlelike probe into it. Microwaves, alcohol, radio waves or a freezing agent are sent through this probe, heating, freezing or in another fashion killing the tumor.

Microwave Ablation (MWA) Advantages and Wide Array of Applicable Uses Cases Drives the Global Tumor Ablation Market

Microwave Ablation (MWA) is a new technology that destroys tumors using heat generated by microwave energy.  Using the technology, the surgeon inserts a small laparoscopic port or open incision to access the tumor. A CT scan or ultrasonic guidance is used to pinpoint the exact location of the tumor. A thin antenna, which emits microwaves is then inserted into the tumor. The probe produces intense heat that ablates (destroys) tumor tissue, mostly within 10 minutes.

The Microwave Ablation (MWA) offers the following advantages over other methods which is fueling its demand:

• Tumor Size Applicability: The technology can be used across wide range of tumor sizes (2 cm – 5 cm)
• Speed: The technology is comparatively faster the other methods and destroys the tumors more efficiently and quickly. It reduces the operation time and the time patients remain under general anesthesia
• Efficiency: The technology is considered more efficient in coagulating blood vessels
• Capability of Multiple Ablations: Using the technology, surgeons can ablate multiple tumors at the same time

However, the technology is not suitable for tumors that are close to major blood vessels or vital organs.

The expanding indications for MWA is another key factor driving its demand. MWA therapy can be applied  to wide range of diseases such as thyroid nodules, lung cancers, liver cancers, breast lumps, pulmonary nodules, among others.

Technological Advancements in Tumor Ablation Fuels the Tumor Ablation Market's Growth

The global tumor ablation market has witnessed a number of technological advancements over the years. The technological advancements in tumor ablation is expected to spur its demand in the upcoming years.

For instance:

• In September 2022, Stryker received 510(k) clearance from the U.S. Food and Drug Administration for its OptaBlate bone tumor ablation system (OptaBlate).
• In September 2021, Novian Health Inc. received Breakthrough Device designation from the U.S. Food and Drug Administration for Novilase Breast Therapy System. Novilase is a minimally invasive procedure that uses laser ablation to destroy tumors as an alternative to surgery. Moreover, in December 2022, Novian Health received Frost & Sullivan’s 2022 European New Product Innovation Award in the breast tumor ablation industry for its Novilase® Breast Therapy system.

Fill out the "Quick Inquiry Form" to request a sample copy

Competitive Landscape Analysis: Tumor Ablation Market

Some of the key players operating in the global tumor ablation market are Medtronic, AngioDynamics, Boston Scientific Corporation,  EDAP TMS, Mermaid Medical, HealthTronics, Bioventus (Misonix), SonaCare  Medical, Ethicon (NeuWave Medical), Merit Medical, among others.

Organic and Inorganic Growth Strategies Adopted by the Market Players to Establish Their Foothold in the Global Tumor Ablation Market

Players operating in this market are adopting organic and inorganic growth strategies such as launching new products, acquiring related firms, and entering into collaborations to garner a higher market share.

For instance,

• In September 2023, Boston Scientific Corporation announced that it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain.
• In November 2022, AngioDynamics entered into a partnership with Minimax Medical for international distribution of their product portfolio including distribution of Minimax Medical’s leading Radiofrequency Ablation System for tumors / nodules on an international level.

The global tumor ablation market is expected to gain further momentum in the upcoming years due to promising prospects of microwave ablation, growing awareness about ablation procedures over conventional therapeutic and surgical procedures, favorable funding and initiatives to support research activities related to tumor ablation and aggressive organic and inorganic growth strategies adopted by the leading market players.

Key Strategic Questions Addressed in this Research Report are as follows:-

• What is the market size and forecast for the global tumor ablation market?
• What are the historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the tumor ablation market?
• What are the major growth drivers, restraints/challenges impacting the global tumor ablation market?
• What are the opportunities prevailing in the tumor ablation market?
• What is the investment landscape of tumor ablation market?
• Which region has the highest share in the market? Which region is expected to witness the highest growth rate in the next 5 years?
• Who are the major players operating in the market? What is the competitive positioning of key players?
• Who are the new players entering the tumor ablation market?
• What are the key strategies adopted by players in global tumor ablation market?